The DOI matches its Crossref record; 202 of the 203 references it cites were found in a registry or an index.
Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects
Open accessAbstract
Regulatory and functional aspects of the kynurenine (K) pathway (KP) of tryptophan (Trp) degradation are reviewed. The KP accounts for ~95% of dietary Trp degradation, of which 90% is attributed to the hepatic KP. During immune activation, the minor extrahepatic KP plays a more active role. The KP is rate-limited by its first enzyme, Trp 2,3-dioxygenase (TDO), in liver and indoleamine 2,3-dioxygenase (IDO) elsewhere. TDO is regulated by glucocorticoid induction, substrate activation and stabilization by Trp, cofactor activation by heme, and end-product inhibition by reduced nicotinamide adenine dinucleotide (phosphate). IDO is regulated by IFN-γ and other cytokines and by nitric oxide. The KP disposes of excess Trp, controls hepatic heme synthesis and Trp availability for cerebral serotonin synthesis, and produces immunoregulatory and neuroactive metabolites, the B 3 “vitamin” nicotinic acid, and oxidized nicotinamide adenine dinucleotide. Various KP enzymes are undermined in disease and are targeted for therapy of conditions ranging from immunological, neurological, and neurodegenerative conditions to cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Trp-Kyn-AhR pathway, in which the essential amino acid tryptophan is converted to Kyn and other secondary metabolites, is the primary route of tryptophan catabolism (19).”
From Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis (2019) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–202 of 202
Inhibition of the Kynurenine Pathway of Tryptophan Metabolism
Frédérick, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_29 · Cited by 2
Clinical Trials Targeting the Kynurenine Pathway
Sheen, M. A., & Soliman, H. H. (2015) · Springer eBooks · doi:10.1007/978-3-319-11870-3_30 · Cited by 1
Research works printed but not linked: 13
- Verjee ZHM, 1975, Acta Vitaminol Enzymol (Milano), 29, 198
- Shibata K, 1986, Agr Biol Chem, 50, 3037
- Murakami Y, 2013, Int J Tryptophan Res, 6, 47
- Nakamura T, 1987, J Biol Chem, 262, 723
- Yamamoto M, 1982, Biochem Int, 5, 747
- Carlson MG, 1993, J Clin Endocrinol Metab, 77, 11
- Chiancone FM, 1964, Ital J Biochem, 13, 1
- Badawy AA-B, 1983, Alcohol Alcohol, 18, 369
- Chouinard G, 1978, Commun Psychopharmacol, 2, 21
- Oxenkrug G, 2016, Ann Psychiatry Ment Health, 4
- Ikeda S, 1986, Ital J Biochem, 35, 232
- Fukuwatari T, 2013, Int J Tryptophan Res, 6, 3
- Zhang LQ, 2011, J Bioanal Biomed, 7, 13
Cited by
Sorted by citations
Neuroinflammation and depression: A review
Troubat, R., Barone, P., Leman, S., Desmidt, T., Cressant, A., Atanasova, B., Brizard, B., El Hage, W., Surget, A., Belzung, C., et al. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14720 · Cited by 1,107
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W. Q., Huang, C., Huber, P., Zhou, X., Li, C. L., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,147
Lieu, E. L., Nguyen, T. A., Rhyne, S., & Kim, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0375-3 · Cited by 847
Bender, M. J., McPherson, A. C., Phelps, C. M., Pandey, S. P., Laughlin, C. R., Shapira, J. H., Medina Sanchez, L., Rana, M., Richie, T. G., Mims, T. S., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.011 · Cited by 732
Cirrhosis-associated immune dysfunction
Albillos, A., Martín‐Mateos, R., der Merwe, V., Wiest, R., Jalan, R., & Álvarez‐Mon, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00520-7 · Cited by 485
Metadata
- Authors
- Badawy, A. A.-B.
- Affiliations
- Cardiff Metropolitan University (GB)
- Corresponding author
- Badawy, Abdulla A-B
- ORCID
- Badawy, Abdulla A-B
- Venue
- International Journal of Tryptophan Research
- Publisher
- SAGE Publications
- Published
- 2017-01-01
- Volume
- 10
- Pages
- 1178646917691938-1178646917691938
- ISSN
- 1178-6469 (ISSN-L)
- PMC
- PMC5398323
- OpenAlex
- W2598111690
- Cited by
- 1,158
- References
- 203
- Citations by year
- 2026: 147 · 2025: 179 · 2024: 137 · 2023: 153 · 2022: 148 · 2021: 148 · 2020: 119 · 2019: 75 · 2018: 45 · 2017: 7
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Tryptophan Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- kynurenine pathway, tryptophan metabolism, tryptophan 2,3-dioxygenase, indoleamine 2,3-dioxygenase, glucocorticoid regulation, nitric oxide, NADP+ inhibition, heme biosynthesis, serotonin synthesis, NAD+, immune regulation, neuroactive metabolites, neurodegenerative diseases, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
